Terumo (TSE:4543) Other Current Liabilities: 円134,259 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

TSE:4543 Terumo Corp TSE:4543
89 GF Score
Price 円2,164.50
GF Value 円3,160.22
Valuation Significantly Undervalued
View Full Analysis

What is Terumo Other Current Liabilities?

Terumo TSE:4543 +0.30% 89 Other Current Liabilities is 円134,259 Mil as of Mar. 2026. GuruFocus rates TSE:4543 with a GF Score™ of 89/100 and a GF Value™ of 円3,160.22 (Significantly Undervalued).

Terumo's other current liabilities for the quarter that ended in Mar. 2026 was 円134,259 Mil.

Terumo's quarterly other current liabilities increased from Sep. 2025 (円106,553 Mil) to Dec. 2025 (円119,959 Mil) and increased from Dec. 2025 (円119,959 Mil) to Mar. 2026 (円134,259 Mil).

Terumo's annual other current liabilities increased from Mar. 2024 (円102,045 Mil) to Mar. 2025 (円111,100 Mil) and increased from Mar. 2025 (円111,100 Mil) to Mar. 2026 (円134,259 Mil).

Terumo Other Current Liabilities Related Terms

Terumo Other Current Liabilities Historical Data

* Premium members only.

The historical data trend for Terumo's Other Current Liabilities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Terumo Other Current Liabilities Chart

Terumo Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Current Liabilities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 80,951.00 85,479.00 102,045.00 111,100.00 134,259.00

Terumo Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Other Current Liabilities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 111,100.00 99,328.00 106,553.00 119,959.00 134,259.00
TSE:4543
89GF Score
Terumo Corp TSE:4543
Other Current Liabilities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Terumo Other Current Liabilities Calculation

The liability a company needs to pay in the next 12 months, but not assigned to Accounts Payable or Debt. For instance, Wal-Mart (WMT) has accrued wages, salaries, valuation, bonuses, insurance liabilities, accrued tax etc. These are all included in other current liabilities.

What does a Other Current Liabilities of 円134,259 Mil mean?
Terumo (TSE:4543) has a Other Current Liabilities of 円134,259 Mil as of Mar. 2026. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Terumo.
Is Terumo's Other Current Liabilities too high?
Terumo's current Other Current Liabilities is 円134,259 Mil. Overall, Terumo has a GF Score™ of 89/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Terumo's Other Current Liabilities compare to ISRG and BDX?
Terumo's Other Current Liabilities of 円134,259 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Current Liabilities for a Medical Devices & Instruments company?
A good Other Current Liabilities depends on the Medical Devices & Instruments industry context. However, Other Current Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Current Liabilities mean?
A high Other Current Liabilities can signal that a stock is expensive relative to its fundamentals. Other current liabilities as record on a company's balance sheet not categorized as standard liabilities. View historical data on Terumo. Terumo's current Other Current Liabilities is 円134,259 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Terumo stock overvalued right now?
Based on GuruFocus' analysis, Terumo (TSE:4543) is currently considered Significantly Undervalued. The stock's GF Value™ is 円3,160.22, compared to a current price of 円2,164.50 — trading 31.5% below its estimated fair value. The current Other Current Liabilities is 円134,259 Mil. Terumo's overall GF Score™ is 89/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Current Liabilities calculated?
Other Current Liabilities is calculated from a company's financial statements. For Terumo (TSE:4543), the current Other Current Liabilities is 円134,259 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Terumo (TSE:4543) Overvalued in 2026?

Based on GuruFocus' analysis, Terumo stock appears to be undervalued. The current stock price of 円2,164.50 is trading 31.5% below its estimated GF Value™ of 円3,160.22. GuruFocus considers Terumo to be Significantly Undervalued.

Key valuation signals for TSE:4543:

  • Other Current Liabilities: 円134,259 Mil
  • GF Value™: 円3,160.22 vs. price of 円2,164.50 (31.5% below fair value)
  • GF Score™: 89/100

No single metric tells the full story. See the TSE:4543 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Terumo Business Description

Address 2-44-1 Hatagaya, Shibuya-ku, Tokyo, JPN, 151-0072
Started as a clinical thermometer producer in Japan in 1921, Terumo is a comprehensive medical device player with a diversified global revenue. Its product portfolio includes prefilled syringes, insulin patch pumps, neurovascular or cardiac vascular interventional devices, and blood processing systems. As of 2025, the cardiac and vascular business is the largest segment, contributing over 60% of its total revenue. Geographically, North America is the largest region, with 38% of Terumo's revenue.
89GF Score

Get the complete analysis for TSE:4543

Other Current Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

円2,164.50
Price
円3,160.22
GF Value